Convalescent plasma (CP) therapy in patients with COVID-19
- PMID: 33257204
- PMCID: PMC7674008
- DOI: 10.1016/j.transci.2020.103018
Convalescent plasma (CP) therapy in patients with COVID-19
Comment on
-
Convalescent plasma therapy in patients with COVID-19.Transfus Apher Sci. 2021 Feb;60(1):102955. doi: 10.1016/j.transci.2020.102955. Epub 2020 Sep 19. Transfus Apher Sci. 2021. PMID: 33011076 Free PMC article.
References
-
- Duan K., Liu B., Li C., Zhang H., et al. The feasibility of convalescent plasma therapy in severe COVID-19 patients: a pilot study. MedRxiv. 2020 March 23Available online: https://www.medrxiv.org/content/10.1101/2020.03.16.20036145v1.full.pdf (accessed on 23 September 2020) - DOI
-
- Cakir B. Do not get confused by the confounders: identification and control of confounders in medical research. J Public Health (Bangkok) 2004;2(1):34–43.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
